1. Up Front

   Up Front 06 July 2020 Pages: 1437 - 1439

   

2. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature

   • Prasad Katulanda
   • Harsha A. Dissanayake
   • David R. Matthews

   Review Open access 14 May 2020 Pages: 1440 - 1452

   

3. Exercising your fat (metabolism) into shape: a muscle-centred view

   • Anne Gemmink
   • Patrick Schrauwen
   • Matthijs K. C. Hesselink

   Review Open access 12 June 2020 Pages: 1453 - 1463

   

4. Exercise and metabolic health: beyond skeletal muscle

   • John P. Thyfault
   • Audrey Bergouignan

   Review 11 June 2020 Pages: 1464 - 1474

   

5. The competitive athlete with type 1 diabetes

   • Michael C. Riddell
   • Sam N. Scott
   • Richard M. Bracken

   Review Open access 12 June 2020 Pages: 1475 - 1490

   

6. Train like an athlete: applying exercise interventions to manage type 2 diabetes

   • Mladen Savikj
   • Juleen R. Zierath

   Review Open access 11 June 2020 Pages: 1491 - 1499

   

7. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

   • Bertrand Cariou
   • Samy Hadjadj
   • for the CORONADO investigators

   Article Open access 29 May 2020 Pages: 1500 - 1515

   

8. Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials

   • Jack A. Sargeant
   • Emer M. Brady
   • Melanie J. Davies

   Short Communication Open access 02 June 2020 Pages: 1516 - 1520

   

9. Pregnancy loss is associated with type 2 diabetes: a nationwide case–control study

   • Pia Egerup
   • Anders P. Mikkelsen
   • Henriette S. Nielsen

   Article 20 May 2020 Pages: 1521 - 1529

   

10. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents

    • Valentino Cherubini
    • Julia M. Grimsmann
    • Dana Dabelea

    Article Open access 08 May 2020 Pages: 1530 - 1541

    

11. Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA_1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes

    • Alison K. Wright
    • Paul Welsh
    • Naveed Sattar

    Article Open access 21 May 2020 Pages: 1542 - 1553

    

12. Sex-specific associations of insulin resistance with chronic kidney disease and kidney function: a bi-directional Mendelian randomisation study

    • Jie V. Zhao
    • C. Mary Schooling

    Article 15 May 2020 Pages: 1554 - 1563

    

13. Islet pericytes convert into profibrotic myofibroblasts in a mouse model of islet vascular fibrosis

    • Luciana Mateus Gonçalves
    • Elizabeth Pereira
    • Joana Almaça

    Article 18 May 2020 Pages: 1564 - 1575

    

14. Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes

    • Kameron B. Rodrigues
    • Matthew J. Dufort
    • Kristin V. Tarbell

    Article 05 June 2020 Pages: 1576 - 1587

    

15. Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice

    • Yasumasa Ikeda
    • Hiroaki Watanabe
    • Toshiaki Tamaki

    Article 19 May 2020 Pages: 1588 - 1602

    

16. Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity

    • Anastasia Kalinovich
    • Nodi Dehvari
    • Tore Bengtsson

    Article Open access 29 May 2020 Pages: 1603 - 1615

    

17. Complex interaction of fasting glucose, body mass index, age and sex on all-cause mortality: a cohort study in 15 million Korean adults

    • Mi-Hyang Jung
    • Sang-Wook Yi
    • Hyeongsu Kim

    Article 19 May 2020 Pages: 1616 - 1625

    

18. Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017

    • Joseph E. O’Reilly
    • Luke A. K. Blackbourn
    • for the Scottish Diabetes Research Network Epidemiology Group

    Article Open access 26 May 2020 Pages: 1626 - 1636

    

19. Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study

    • Katie Harris
    • Megumi Oshima
    • Mark Woodward

    Article Open access 08 May 2020 Pages: 1637 - 1647

    

20. Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study

    • Jeroen H. P. M. van der Velde
    • Annemarie Koster
    • Nicolaas C. Schaper

    Article Open access 15 June 2020 Pages: 1648 - 1658

    

21. Sufficient increment of sulfonylurea without reintroduction of insulin ameliorates pubertal deterioration of glycaemic control in KCNJ11 neonatal diabetes treated with long-term sulfonylurea

    • Shigeru Suzuki
    • Tokuo Mukai
    • Hiroshi Azuma

    Research Letter 24 May 2020 Pages: 1659 - 1661

    

22. Diabetic retinopathy: looking beyond the eyes

    • Rafael Simó
    • Coen D. A. Stehouwer
    • Angelo Avogaro

    Letter 18 June 2020 Pages: 1662 - 1664

    

23. Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?

    • Anette-Gabriele Ziegler
    • Ezio Bonifacio

    Letter Open access 26 May 2020 Pages: 1665 - 1666

24. Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD)

    • John B. Buse
    • Deborah J. Wexler
    • Melanie J. Davies

    Correction 15 May 2020 Pages: 1667 - 1667